Yu Huan Ting

Mr. Yu Huan Ting

University of South Australia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Ruixiu LiRuixiu Li
Ruixiu Li
Yu Huan TingYu Huan Ting
Yu Huan Ting
SYSouha Hosam Youssef
Souha Hosam Youssef
YSYunmei Song
Yunmei Song
Sanjay GargSanjay Garg
Sanjay Garg
As a variety of novel technologies, 3D printing has been considerably applied in the field of health care, including cancer treatment. With its fast prototyping nature, 3D printing could transform basic oncology discoveries to clinical use quickly, speed up and even revolutionise the whole drug discovery and development process. This literature review provides insight into the up-to-date applications of 3D printing on cancer research and treatment, from fundamental research and drug discovery to drug development and clinical applications. These include 3D printing of anticancer pharmaceutics, 3D-bioprinted cancer cell models and customised nonbiological medical devices. Finally, the challenges of 3D printing for cancer applications are elaborated, and the future of 3D-printed medical applications is envisioned.